Skip to main content
Equibles

Bank of New York Mellon Corp

Bank

Position in ZNTL — Zentalis Pharmaceuticals, Inc.

CIK 1390777 NEW YORK, NY
Back to ZNTL Full portfolio

Position in ZNTL

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$592,028
+$343,807 QoQ
Shares Held
122,068
-21.8% QoQ
Ownership
0.170%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#47
of 114 holders
Holding Since
Jun 2020
21 quarters on record
Voting authority Sole 86% Shared 0% None 14%

Common Shares in ZNTL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Bank of New York Mellon Corp holds $4,864,365,655 across 311 Biotechnology names. ZNTL ranks #229 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,672,623 $830,842,010
2 REGN
Regeneron Pharmaceuticals, Inc.
 758,492 $472,950,091
3 JAZZ
Jazz Pharmaceuticals plc
 1,578,013 $380,253,782
4 ALNY
Alnylam Pharmaceuticals, Inc.
 492,071 $148,128,128
5 INSM
INSMED Inc
 1,312,756 $139,966,036
6 MRNA
Moderna, Inc.
 1,701,675 $119,168,293
7 RVMD
Revolution Medicines, Inc.
 601,056 $112,565,759
8 INCY
Incyte Corp
 972,825 $110,279,435

All Filings in ZNTL

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $592,028 122,068
2025-03-31 $248,221 156,115
2024-12-31 $493,692 162,935
2024-09-30 $637,779 173,310
2024-06-30 $1,364,909 333,719
2024-03-31 $4,568,508 289,880
2023-12-31 $4,395,560 290,136
2023-09-30 $4,856,705 242,109
2023-06-30 $4,641,587 164,537
2023-03-31 $2,675,494 155,552
2022-12-31 $3,185,844 158,185
2022-09-30 $3,309,821 152,808
2022-06-30 $3,326,448 118,379
2022-03-31 $6,625,840 143,603
2021-12-31 $12,073,369 143,628
2021-09-30 $9,238,103 138,627
2021-06-30 $5,045,913 94,848
2021-03-31 $3,896,464 89,801
2020-12-31 $5,018,545 96,622
2020-09-30 $1,089,197 33,319
2020-06-30 $1,496,399 31,162